Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease

Figure 1 Area under the receiver operating characteristic curve of albumin-bilirubin, fibrosis-4 and prognostic scores from multivariable logistic regression including determinants. A: 8-year liver-related complications; B: 8-year all-cause mortality. AUROC: Area under the receiver operating characteristic curve; ALBI: Albumin-bilirubin; FIB-4: Fibrosis-4.

Figure 2 Kaplan-Meier plot of estimated. A: 8-year liver-related complications; B: 8-year all-cause mortality according to the optimum cut point of albumin-bilirubin. Short-dashed line with shaded areas indicates a 95% confidence interval. ALBI: Albumin-bilirubin.

Figure 3 Area under the receiver operating characteristic curve of albumin-bilirubin, fibrosis-4 determinants. A: 8-year liver-related complications in advance fibrosis group; B: 8-year all- cause mortality in advance fibrosis group; C: 8-year liver-related complications in non-advance fibrosis group; D: 8-year all caused mortality in non-advance fibrosis group. AUROC: Area under the receiver operating characteristic curve; ALBI: Albumin-bilirubin; FIB-4: Fibrosis-4.